<DOC>
	<DOCNO>NCT03094403</DOCNO>
	<brief_summary>A Multi-Center , Double-Blind , Randomized , Placebo Controlled , Parallel-Group Study</brief_summary>
	<brief_title>To Evaluate Therapeutic Equivalence Safety Azelaic Acid 15 % Topical Gel</brief_title>
	<detailed_description>A Multi-Center , Double-Blind , Randomized , Placebo Controlled , Parallel-Group Study , compare AZELAIC ACID TOPICAL GEL 15 % TO FINACEA® active treatment Placebo Control treatment Moderate Facial Rosacea .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Healthy male nonpregnant female ≥ 18 yearsofage clinical diagnosis moderate facial rosacea ; Subjects definite clinical diagnosis facial rosacea severity Grade 3 per IGE Female subject pregnant , nursing , plan become pregnant study participation ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>